We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Agilent Technologies Presents Thought Leader Award to Professor Dwight Stoll for Separation Science Research

Agilent Technologies Presents Thought Leader Award to Professor Dwight Stoll for Separation Science Research content piece image
Gustavus Chemistry Professor Dwight Stoll. Gustavus Adolphus College
Listen with
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: 1 minute

Agilent Technologies Inc. announced today that Prof. Dwight Stoll has received an Agilent Thought Leader Award in support of his research applying two-dimensional liquid chromatography (2D-LC) to biopharmaceutical analysis.

An influential researcher in chromatography, Prof. Stoll specializes in multi-dimensional separations, which enables scientists to isolate the components of complex samples with greater ease and clarity.

“I am honored to receive this award, and very excited about Agilent’s support of the vision of my laboratory and our collaborators, as we focus on the development of next-generation analytical tools based on 2D-LC for the biopharmaceutical research area,” said Prof. Stoll, associate professor of analytical chemistry at Gustavus Adolphus College in Saint Peter, Minnesota.

Prof. Stoll will lead a project on the use of 2D-LC in biopharmaceutical analysis that includes several international experts: Prof. Michael Lämmerhofer of the University of Tuebingen, Germany; Dr. Douglas Richardson of Merck Research Laboratories, Kenilworth, NJ, USA; and Dr. Davy Guillarme of the University of Geneva, Switzerland.  

“We are pleased to support Dr. Stoll’s research using Agilent’s transformative 2D-LC technology, which has the potential to resolve key challenges that biopharmaceutical scientists face when analyzing complex samples,” said Dr. Stefan Schuette, vice president and general manager Liquid Phase Separations Division at Agilent Technologies. “The collaborative nature of the research of Dr. Stoll and his international colleagues, combining both academia and industry, will undoubtedly accelerate the progress of these types of solutions for the biopharma industry.”

Schuette noted that the high separation power of Agilent’s 2D-LC technology makes it ideal for the analysis of highly complex biopharmaceuticals, whether used for comprehensive screening or detailed determination of specific peptides.

The Agilent Technologies Thought Leader Award promotes fundamental scientific advances by contributing financial support, products and expertise to the research of influential thought leaders in the life sciences, diagnostics and applied chemical markets. Information about previous award recipients is available by visiting the Agilent Thought Leader Program web page.

This article has been republished from materials provided by Agilent Technologies Inc.. Note: material may have been edited for length and content. For further information, please contact the cited source.